Showing results (1521-1530 of 6,919) with videos related to

Sort By:
Pageof 692
Rheumatology International|January 30, 2025
Severity of skin disease strongly correlates with quality of life in people with psoriatic arthritis: a systematic reviewChiara Pitzalis, Nikki Myall, Mrinalini Dey, et al.
Rheumatology International|September 9, 2024
SARS-CoV-2 as a trigger of IgA vasculitis: a clinical case and literature reviewAkerke Auanassova, Marlen Yessirkepov, Burhan Fatih Kocyigit
Rheumatology International|August 27, 2024
What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping reviewMario Termine, Zoe Davidson, Tammie Choi, et al.
Rheumatology International|August 29, 2024
Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging featuresJing Zhao, Ying Long, Shengtao Li, et al.
Rheumatology International|August 24, 2024
Association of serum and synovial adipokines (chemerin and resistin) with inflammatory markers and ultrasonographic evaluation scores in patients with knee joint osteoarthritis- a pilot studyEmanuela Vasileva, Teodora Stankova, Konstantin Batalov, et al.
Rheumatology International|August 24, 2024
Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational studyStylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, et al.
Rheumatology International|August 27, 2024
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reportsChristian R Klein, Annkristin Heine, Peter Brossart, et al.
Rheumatology International|August 21, 2024
Development and validation of a predictive model for end-stage renal disease in systemic lupus erythematosus patientsQiang Xu, Rui Liang, Jiesi Luo, et al.
Rheumatology International|August 13, 2024
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR networkPatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Rheumatology International|August 10, 2024
Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide studyHannah Labinsky, Lea-Kristin Nagler, Martin Krusche, et al.
Pageof 692